 Bicalutamide is known to have a small risk of elevated liver enzymes and hepatotoxicity at dosages of 50 mg/day and above.As a result, it is recommended that liver function tests (LFTs) periodically be performed.One recommended procedure is to check LFTs at baseline, at one month, at two months, and then every 6 months thereafter, for lifetime.